Firefly Neuroscience enters $1M private placement; units include common stock and warrants

FIREFLY NEUROSCIENCE, INC.

Up to 666,667 units at $1.50/unit, aggregate gross proceeds up to $1,000,000.
Each unit: 1 share common stock, 1 5-yr warrant at $1.88 exercise, 1 5-yr warrant at $2.50 exercise.
Warrants not exercisable until shareholder approval obtained; company must seek approval within 90 days.
Closing conditional on effective registration statement (due May 21, 2026) and shareholder approval.
Investor can terminate if common stock closing price below $1.50 on day of approval.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

FIREFLY NEUROSCIENCE, INC. entered into Purchase Agreement with an accredited investor valued at aggregate gross proceeds of up to $1,000,000 (effective 2026-05-06).

Action: entry
Agreement: equity purchase
Counterparty: an accredited investor
Value: aggregate gross proceeds of up to $1,000,000
Effective: 2026-05-06

Exact text from the filing

On May 6, 2026, Firefly Neuroscience, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”), pursuant to which the Company agreed to issue and sell to the Investor up to 666,667 units (each a “Unit” and, collectively, the “Units”), at a purchase price of $1.50 per Unit, for aggregate gross proceeds of up to $1,000,000.

View on SEC.gov

629 material agreements filed in the last 30 days. Browse all material agreements →

FIREFLY NEUROSCIENCE, INC. filing history →

Source: SEC EDGAR

accession 0001213900-26-055110

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.